SCHEMBL18590010

SCHEMBL18590010

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)C4(c6ccccc6-5)c5ccccc5-c5oc6ccccc6c54)c4ccccc34)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
PDK2 Q15119 3/20 0.36
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
CYP3A4 P08684 2/20 0.32
KMT2A Q03164 2/20 0.32
ALOX5 P09917 1/20 0.32
DDR2 Q16832 1/20 0.32
CA12 O43570 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32
CALM1 P0DP23 1/20 0.32
AR P10275 1/20 0.32
PKM P14618 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18582604 0.99 PLA2G2A (0.37) PLA2G2APLA2G4AL3MBTL1PDK2CA1
SCHEMBL18590021 0.89 L3MBTL1 (0.33) PLA2G2APLA2G4AL3MBTL1PDK2KMT2A
SCHEMBL18590011 0.88 L3MBTL1 (0.34) L3MBTL1KDM4EMEN1KMT2AALOX5
SCHEMBL18590018 0.88 L3MBTL1 (0.34) L3MBTL1ALOX5CYP1B1NTRK1PLK3
SCHEMBL18590015 0.88 L3MBTL1 (0.32) PLA2G2APLA2G4AL3MBTL1KMT2AMAPK1
SCHEMBL18582836 0.87 L3MBTL1 (0.34) PLA2G2APLA2G4AL3MBTL1PDK2KDM4E
SCHEMBL18590045 0.87 PDK2 (0.35) PLA2G2APLA2G4AL3MBTL1PDK2CA1
SCHEMBL18590033 0.87 PDK2 (0.42) L3MBTL1PDK2KDM4EMEN1KMT2A
SCHEMBL20174211 0.86 PDK2 (0.34) PLA2G2APLA2G4AL3MBTL1PDK2CA1
SCHEMBL18590041 0.86 PDK2 (0.35) PLA2G2APLA2G4AL3MBTL1PDK2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10170703-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-01-01 US disclosed
US-20170069847-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2017-03-09 US disclosed
US-20170069847-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2017-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170069847-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PLA2G2A 4550/4885PLA2G4A 4471/4885L3MBTL1 1571/4885
US-10170703-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PLA2G2A 4550/4885PLA2G4A 4471/4885L3MBTL1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.